AU1339701A - Anti-cancer nucleic acid and protein targets - Google Patents
Anti-cancer nucleic acid and protein targetsInfo
- Publication number
- AU1339701A AU1339701A AU13397/01A AU1339701A AU1339701A AU 1339701 A AU1339701 A AU 1339701A AU 13397/01 A AU13397/01 A AU 13397/01A AU 1339701 A AU1339701 A AU 1339701A AU 1339701 A AU1339701 A AU 1339701A
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- protein targets
- cancer nucleic
- cancer
- targets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108091005461 Nucleic proteins Proteins 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16123299P | 1999-10-22 | 1999-10-22 | |
| US60161232 | 1999-10-22 | ||
| US69378300A | 2000-10-19 | 2000-10-19 | |
| US09693783 | 2000-10-19 | ||
| PCT/US2000/029126 WO2001030964A2 (en) | 1999-10-22 | 2000-10-20 | Anti-cancer nucleic acid and protein targets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1339701A true AU1339701A (en) | 2001-05-08 |
Family
ID=26857637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU13397/01A Abandoned AU1339701A (en) | 1999-10-22 | 2000-10-20 | Anti-cancer nucleic acid and protein targets |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1339701A (en) |
| WO (1) | WO2001030964A2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002215689B2 (en) * | 2000-12-11 | 2006-05-18 | Biosceptre Pty Ltd | P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| AU2002244112B2 (en) * | 2001-02-21 | 2007-05-10 | Novartis Vaccines And Diagnostics, Inc. | TTK in diagnosis and as a therapeutic target in cancer |
| AU2007203399B2 (en) * | 2001-02-21 | 2009-12-03 | Novartis Vaccines And Diagnostics, Inc. | TTK in diagnosis and as a therapeutic target in cancer |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030045491A1 (en) | 2001-02-23 | 2003-03-06 | Christoph Reinhard | TTK in diagnosis and as a therapeutic target in cancer |
| US7867731B2 (en) | 1998-11-04 | 2011-01-11 | Novartis Vaccines And Diagnostics, Inc. | HX2004-6 polypeptide expressed in cancerous cells |
| AUPR201500A0 (en) * | 2000-12-11 | 2001-01-11 | Biosceptre Pty Ltd | Methods for identifying pre-neoplastic and neoplastic states in mammals |
| PT1360203E (en) | 2001-01-17 | 2009-04-03 | Intreat Pty Ltd | Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions |
| WO2002061432A2 (en) * | 2001-02-01 | 2002-08-08 | Lifespan Biosciences, Inc. | Gpr22, a g protein-coupled receptor (gpcr) and compositions and methods related thereto |
| US7501242B2 (en) | 2001-02-21 | 2009-03-10 | Novartis Vaccines And Diagnostics, Inc. | Detection of colon or breast cancer by measuring TTK polynucleotide expression |
| WO2002099140A1 (en) * | 2001-06-05 | 2002-12-12 | Exelixis, Inc. | GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| US20050008643A1 (en) * | 2001-06-27 | 2005-01-13 | Ora Bernard | Diagnostic methods and agents |
| NZ554740A (en) | 2002-05-24 | 2009-01-31 | Schering Corp | Neutralizing human anti-IGFR antibody |
| EP1382969A1 (en) * | 2002-07-17 | 2004-01-21 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diagnosis and prevention of cancer cell invasion |
| WO2005047512A2 (en) | 2003-11-12 | 2005-05-26 | Shering Corporation | Plasmid system for multigene expression |
| AR046639A1 (en) | 2003-11-21 | 2005-12-14 | Schering Corp | ANTI-IGFR1 ANTIBODY THERAPEUTIC COMBINATIONS |
| US8415315B2 (en) * | 2004-05-06 | 2013-04-09 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for inhibiting the proliferation of cancer cells |
| WO2006060419A2 (en) | 2004-12-03 | 2006-06-08 | Schering Corporation | Biomarkers for pre-selection of patients for anti-igf1r therapy |
| WO2006138696A2 (en) * | 2005-06-17 | 2006-12-28 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| AU2007306924A1 (en) | 2006-10-10 | 2008-04-17 | Biosceptre International Limited | Hybridomas producing antibodies against non functional P2X7 receptor |
| WO2009033234A1 (en) | 2007-09-14 | 2009-03-19 | Biosceptre International Limited | Purinergic (p2x) receptors in extra-cellular body fluid |
| AU2008299593B2 (en) | 2007-09-14 | 2013-04-18 | Biosceptre International Limited | Novel P2X7 epitopes |
| BRPI0915367B8 (en) | 2008-07-04 | 2021-05-25 | Biosceptre International Ltd | anti-p2x7 peptide |
| EP2966090B1 (en) | 2009-08-20 | 2018-10-10 | Biosceptre (Aust) Pty Ltd | Anti p2x7 receptor antibodies and fragments thereof |
| AU2010336032C1 (en) | 2009-12-24 | 2016-04-21 | Biosceptre International Limited | Antibodies to non-functional oligomeric P2X7 receptors |
| US9562094B2 (en) | 2010-09-10 | 2017-02-07 | Biosceptre (Aust) Pty Ltd | Companion animal treatments |
| CN103702683B (en) | 2011-07-01 | 2017-07-04 | 生物权威(澳大利亚)有限责任公司 | Therapeutic alliance |
-
2000
- 2000-10-20 AU AU13397/01A patent/AU1339701A/en not_active Abandoned
- 2000-10-20 WO PCT/US2000/029126 patent/WO2001030964A2/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002215689B2 (en) * | 2000-12-11 | 2006-05-18 | Biosceptre Pty Ltd | P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| AU2002244112B2 (en) * | 2001-02-21 | 2007-05-10 | Novartis Vaccines And Diagnostics, Inc. | TTK in diagnosis and as a therapeutic target in cancer |
| AU2007203399B2 (en) * | 2001-02-21 | 2009-12-03 | Novartis Vaccines And Diagnostics, Inc. | TTK in diagnosis and as a therapeutic target in cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001030964A2 (en) | 2001-05-03 |
| WO2001030964A3 (en) | 2001-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1339701A (en) | Anti-cancer nucleic acid and protein targets | |
| AU3510200A (en) | Human dickkopf-related protein and nucleic acid molecules and uses therefor | |
| AU2001292561A1 (en) | Nucleic acids and polypeptides | |
| AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
| AU5471600A (en) | Variant tlr4 nucleic acid and uses thereof | |
| AU6458400A (en) | Nucleic acid, polypeptides, assays, therapeutic methods and means | |
| AU5013200A (en) | Target independent assay systems and methods | |
| AU5245900A (en) | Novel protein and dna thereof | |
| AU5178999A (en) | Nucleic acid delivery | |
| AU7987800A (en) | Anti-aging nucleic acid and protein targets | |
| AU1891301A (en) | Novel polypeptide and dna thereof | |
| AU2001274566A1 (en) | Novel protein and dna thereof | |
| AU3511100A (en) | Novel nucleic acids and polypeptides | |
| AU1855001A (en) | A new member of the pak protein family, nucleic acids and methods related to thesame | |
| AU2136401A (en) | P450rai-2 and related proteins | |
| AU2153401A (en) | Gene expression in biological conditions | |
| AU2225401A (en) | Novel protein and dna thereof | |
| AU2002367841A1 (en) | Bsnd nucleic acids and proteins | |
| AU2001259240A1 (en) | Novel stmst protein and nucleic acid mocecules and uses therefor | |
| AU1690200A (en) | Novel protein and dna thereof | |
| AU2813700A (en) | Protein assay | |
| AU5494700A (en) | Rna metabolism proteins | |
| AU3364401A (en) | Modified nucleic acids and their use | |
| AU5447999A (en) | Novel protein and dna thereof | |
| AU2003265635A1 (en) | Nphp nucleic acids and proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |